{"id":"https://openalex.org/W2909026730","doi":"https://doi.org/10.1182/blood-2018-99-110185","title":"Transplant Associated Thrombotic Microangiopathy (TA-TMA): Lessons Learned from a Large Pediatric Center","display_name":"Transplant Associated Thrombotic Microangiopathy (TA-TMA): Lessons Learned from a Large Pediatric Center","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2909026730","doi":"https://doi.org/10.1182/blood-2018-99-110185","mag":"2909026730"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-110185","doi":"https://doi.org/10.1182/blood-2018-99-110185","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-110185","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046929879","display_name":"Michelle Long Schoettler","orcid":"https://orcid.org/0000-0003-4565-6399","observed_orcids":["https://orcid.org/0000-0003-4565-6399"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Schoettler","raw_affiliation_strings":["Boston Children's/ Dana Farber Center for Cancer and Blood Disorders, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Children's/ Dana Farber Center for Cancer and Blood Disorders, Boston, MA","institution_ids":["https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008479139","display_name":"Leslie Lehmann","orcid":"https://orcid.org/0000-0001-5558-4830","observed_orcids":["https://orcid.org/0000-0001-5558-4830"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie E. Lehmann","raw_affiliation_strings":["Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston,","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053168617","display_name":"Pei\u2010Chi Kao","orcid":"https://orcid.org/0000-0003-0702-8324","observed_orcids":["https://orcid.org/0000-0003-0702-8324"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Pei-Chi Kao","raw_affiliation_strings":["45 Brookline Avenue, Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"45 Brookline Avenue, Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049590639","display_name":"Maia Lee","orcid":"https://orcid.org/0000-0002-5992-9477","observed_orcids":["https://orcid.org/0000-0002-5992-9477"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Maia Lee","raw_affiliation_strings":["Boston Children's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Children's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085349348","display_name":"Clement Ma","orcid":"https://orcid.org/0000-0002-8188-9600","observed_orcids":["https://orcid.org/0000-0002-8188-9600"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Clement Ma","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110543173","display_name":"Christine Duncan","orcid":"https://orcid.org/0000-0002-2090-4897","observed_orcids":["https://orcid.org/0000-0002-2090-4897"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Duncan","raw_affiliation_strings":["Department of Pediatric Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5049590639","https://openalex.org/A5053168617","https://openalex.org/A5085349348"],"corresponding_institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"2090","last_page":"2090"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/transplant-associated-thrombotic-microangiopathy","display_name":"transplant-associated thrombotic microangiopathy","score":0.9229999780654907},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.8709999918937683},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.8180000185966492},{"id":"https://openalex.org/keywords/prevalence","display_name":"prevalence","score":0.4490000009536743},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.5789999961853027},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6079999804496765},{"id":"https://openalex.org/keywords/acute-graft-versus-host-disease","display_name":"acute graft-versus-host disease","score":0.8140000104904175},{"id":"https://openalex.org/keywords/schistocytes","display_name":"schistocytes","score":0.6830000281333923},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.6869999766349792},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.39500001072883606},{"id":"https://openalex.org/keywords/competing-risk-analysis","display_name":"competing risk analysis","score":0.4790000021457672},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6480000019073486},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.4320000112056732},{"id":"https://openalex.org/keywords/allogeneic-transplantation","display_name":"allogeneic transplantation","score":0.5199999809265137},{"id":"https://openalex.org/keywords/autologous-transplantation","display_name":"autologous transplantation","score":0.7149999737739563},{"id":"https://openalex.org/keywords/post-transplant-complications","display_name":"post-transplant complications","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8373068571090698},{"id":"https://openalex.org/C2777878052","wikidata":"https://www.wikidata.org/wiki/Q3312044","display_name":"Thrombotic microangiopathy","level":3,"score":0.7762572765350342},{"id":"https://openalex.org/C65245452","wikidata":"https://www.wikidata.org/wiki/Q623225","display_name":"Schistocyte","level":4,"score":0.5961133241653442},{"id":"https://openalex.org/C191093355","wikidata":"https://www.wikidata.org/wiki/Q9250577","display_name":"Exact test","level":2,"score":0.5517777800559998},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.533018171787262},{"id":"https://openalex.org/C2780073493","wikidata":"https://www.wikidata.org/wiki/Q7523837","display_name":"Single Center","level":2,"score":0.500622034072876},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.492397665977478},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4911915957927704},{"id":"https://openalex.org/C2781127562","wikidata":"https://www.wikidata.org/wiki/Q2063651","display_name":"Microangiopathic hemolytic anemia","level":4,"score":0.46927157044410706},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.46270325779914856},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44307464361190796},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4285799562931061},{"id":"https://openalex.org/C2778585876","wikidata":"https://www.wikidata.org/wiki/Q1426491","display_name":"Thrombotic thrombocytopenic purpura","level":3,"score":0.41943103075027466},{"id":"https://openalex.org/C2780921031","wikidata":"https://www.wikidata.org/wiki/Q14873945","display_name":"ADAMTS13","level":4,"score":0.41422346234321594},{"id":"https://openalex.org/C66339696","wikidata":"https://www.wikidata.org/wiki/Q6089397","display_name":"Log-rank test","level":3,"score":0.41124871373176575},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3877827227115631},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35046565532684326},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.34725627303123474},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.17926368117332458},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.15117719769477844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-110185","doi":"https://doi.org/10.1182/blood-2018-99-110185","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-110185","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3033416765","https://openalex.org/W4400512835","https://openalex.org/W2923881376","https://openalex.org/W4417007590","https://openalex.org/W4406399875","https://openalex.org/W3028237460","https://openalex.org/W4389248552","https://openalex.org/W3113832250","https://openalex.org/W1843581822","https://openalex.org/W4391603971"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Transplant":[2],"associated":[3],"thrombotic":[4],"microangiopathy":[5],"(TA-TMA)":[6],"is":[7,26,34,67,71,585,652],"a":[8,18,21,91,171,189,192,258,314,393,432,518,619],"well-recognized":[9],"complication":[10],"of":[11,24,88,108,126,188,287,316,335,364,396,439,460,490,505,554,566,580,598,618,625,644,675],"hematopoietic":[12],"cell":[13,276,323,378],"transplantation":[14],"(HCT)":[15],"and":[16,43,59,86,152,185,191,202,218,306,342,351,366,381,420,451,493,570,635,646,665,669],"in":[17,128,181,269,346,374,388,522,622],"pediatric":[19,94],"cohort,":[20],"prevalence":[22,85,579],"rate":[23],"39%":[25],"reported":[27],"(Jodele,":[28],"et":[29,142],"al":[30],"2016).":[31],"However,":[32],"TA-TMA":[33,74,89,127,139,207,311,330,469,480,523,541,581,604,630,664],"challenging":[35],"to":[36,42,73,76,82,136,149,355,502,517,654,659,677],"diagnose":[37],"as":[38],"features":[39],"are":[40,62],"common":[41],"may":[44],"occur":[45,150],"concurrently":[46,151],"with":[47,390,392,479,486,629],"many":[48],"post":[49],"HCT":[50,114,368,382],"complications,":[51],"i.e.":[52],"acute":[53],"graft":[54],"versus":[55,417],"host":[56],"disease":[57],"(aGVHD)":[58],"infection.":[60],"Outcomes":[61],"historically":[63],"poor,":[64],"though":[65],"it":[66],"unclear":[68,567],"if":[69],"this":[70,98],"secondary":[72],"or":[75,170,176,343],"concurrent":[77],"morbid":[78],"conditions.":[79],"We":[80],"aimed":[81],"describe":[83],"the":[84,105,129,146,182,347,437,458,475,532,548,552,592,616,623,642],"outcomes":[87],"at":[90,115,154,376,412,526,551,582],"single":[92],"large":[93],"center.":[95],"Methods:":[96],"In":[97,431],"retrospective":[99],"study,":[100],"data":[101],"were":[102,122,198,208,224,230,239,267,303,352,371,484,545,605],"extracted":[103],"from":[104,119,515],"medical":[106],"records":[107],"all":[109,145],"children":[110],"who":[111,197,326,535,600],"received":[112,540],"an":[113,357,361],"Boston":[116],"Children's":[117],"Hospital":[118],"1/2015-08/2017.":[120],"Records":[121],"reviewed":[123],"for":[124,206,211,226,232,262,300,329,436,468,499,547,603,611,641,663],"evidence":[125],"first":[130,348],"100":[131,349,413],"days":[132,318,350,414],"after":[133,322],"HCT.":[134],"According":[135],"\"probable":[137],"diagnostic":[138,594],"criteria\"":[140],"(Cho":[141],"al,":[143],"2010),":[144],"following":[147],"had":[148,331,511,631],"during":[153],"least":[155],"2":[156,488,494,509],"consecutive":[157],"time":[158,286,553],"points:":[159],"1)":[160],"elevated":[161],"lactate":[162],"dehydrogenase,":[163],"2)":[164],"platelet":[165],"count":[166],"<50":[167],"\u00d7":[168],"109/L":[169],"\u226550%":[172],"decrease,":[173],"3)":[174],"anemia":[175],"requiring":[177],"transfusions,":[178],"4)":[179],"schistocytes":[180],"peripheral":[183],"blood,":[184],"5)":[186],"absence":[187],"coagulopathy":[190],"negative":[193],"Coombs":[194],"test.":[195,250],"Patients":[196,325,628],"both":[199,411],"clinically":[200,304],"diagnosed":[201,305,313,478],"retrospectively":[203,308,536,606],"met":[204,298,309,327,537,601],"criteria":[205,299,328,538,602],"grouped":[209],"together":[210],"analysis.":[212],"Fisher's":[213],"exact":[214],"test":[215,221,427],"(categorical":[216],"variables)":[217,223],"Wilcoxon":[219],"rank-sum":[220],"(continuous":[222],"used":[225],"comparison.":[227],"Kaplan-Meier":[228],"curves":[229],"generated":[231],"overall":[233,633],"survival":[234,634],"(OS).":[235],"All":[236,544],"non-relapse":[237],"deaths":[238],"considered":[240],"transplant-related":[241],"(TRM).":[242],"Competing":[243],"risk":[244,459,661],"analysis":[245,254],"was":[246,255,278,289,312,385,408,462,529,575],"performed":[247,256,268],"using":[248,257,591],"Gray's":[249],"Multivariable":[251],"competing":[252],"risks":[253],"proportional":[259],"hazards":[260],"model":[261,434],"TRM.":[263],"Results:":[264],"275":[265],"HCTs":[266],"232":[270],"patients.":[271],"Among":[272],"allogenic":[273],"transplants":[274],"(n=163),":[275],"source":[277],"largely":[279],"bone":[280],"marrow":[281],"(87%).":[282],"Median":[283],"follow":[284],"up":[285],"survivors":[288],"1.3":[290],"years":[291,501],"(range":[292,319],"0.04-2.9":[293],"years).":[294],"Thirty-seven":[295],"patients":[296,389,477,510,534,599],"(16%)":[297],"TA-TMA;":[301],"6":[302,476],"31":[307,533],"criteria.":[310,595,627],"median":[315],"26":[317],"11-97":[320],"days)":[321],"infusion.":[324],"significantly":[332,386,409,463],"higher":[333,410,464],"rates":[334],"aGVHD,":[336],"ICU":[337],"admissions,":[338],"engraftment":[339,452,559,647],"failure,":[340],"bacterial":[341],"viral":[344],"infections":[345],"more":[353],"likely":[354],"have":[356],"unrelated":[358],"donor":[359],"HCT,":[360,377],"HLA-loci":[362],"mismatch":[363],"<10/10,":[365],"\u00b32":[367,500],"(p<0.05).":[369],"There":[370],"no":[372],"differences":[373],"age":[375],"source,":[379],"sex":[380],"indication.":[383],"OS":[384,395],"lower":[387,587],"TA-TMA,":[391],"one-year":[394],"63.1%":[397],"(95%":[398],"CI=46.8-79.3%)":[399],"vs":[400,424],"92.1%":[401],"(87.9-96.2%),":[402],"(log-rank":[403],"p<0.0001;":[404,428],"Figure":[405,429],"1A).":[406],"TRM":[407,461,525,574],"16.2%":[415],"(6.5-29.9%)":[416],"2.4%":[418],"(0.8-5.6%),":[419],"one":[421],"year":[422,528],"37%":[423],"2.4%.":[425],"(Gray's":[426],"1B).":[430],"multivariable":[433],"adjusting":[435,640],"development":[438,643],"grade":[440],"4":[441],"aGVHD":[442,512,557,645],"(Hazard":[443],"ratio":[444],"[HR]=4.4,":[445],"95%":[446,455,471],"CI=1.2":[447],"-":[448],"15.7,":[449],"p=0.02)":[450],"failure":[453,492,560,565,648],"(HR=2.1,":[454],"CI=0.4-9.9,":[456],"p=0.4),":[457],"when":[465,639],"screening":[466],"positive":[467,555],"(HR=9.1,":[470],"CI=3.2-25.8,":[472],"p<0.0001).":[473],"Of":[474,531],"by":[481],"providers,":[482],"4/6":[483],"treated":[485,546,610],"eculizumab;":[487],"died":[489],"multiorgan":[491,564],"remained":[495],"dependent":[496],"on":[497],"eculizumab":[498],"maintain":[503],"control":[504],"disease.":[506],"The":[507,578],"other":[508,571,589],"prophylaxis":[513],"switched":[514],"cyclosporine":[516],"different":[519],"agent,":[520],"resulting":[521],"resolution.":[524],"1":[527],"33%.":[530],"none":[539],"directed":[542],"therapy.":[543],"primary":[549],"condition":[550],"screening:":[556],"(n=9),":[558],"(n=4),":[561],"infection":[562],"(n=6),":[563],"etiology":[568],"(n=2)":[569],"(n=16).":[572],"One-year":[573],"38.2%.":[576],"Conclusion:":[577],"our":[583],"institution":[584],"16%,":[586],"than":[588],"reports":[590],"same":[593],"83%":[596],"(31/37)":[597],"identified":[607],"while":[608],"being":[609],"another":[612],"transplant":[613],"complication,":[614],"highlighting":[615],"challenge":[617],"clinical":[620],"diagnosis":[621],"setting":[624],"non-specific":[626],"worse":[632],"increased":[636],"TRM,":[637],"even":[638],"(HR":[649],"9.1).":[650],"It":[651],"important":[653],"develop":[655],"multi-institutional,":[656],"prospective":[657],"studies":[658],"identify":[660],"factors":[662],"further":[666],"study":[667],"therapies":[668],"outcomes.":[670],"Disclosures":[671],"No":[672],"relevant":[673],"conflicts":[674],"interest":[676],"declare.":[678]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2019-01-25T00:00:00"}